AVIR · Company research
Atea Pharmaceuticals, Inc. (AVIR): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 5.07 | $409,454,714.68 | 330137714.68 | 3.7591240875912409 | — | — | — | 1.7519852238467496 | — |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.